newsfilter
← Latest News
GlobeNewswire·

Ocular Therapeutix™ to Participate in November and December Investor Conferences

BEDFORD, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation